Context Capital Management’s 4D Pharma PLC LBPS Stock Holding History

Context Capital Management’s Portfolio LBPS Stock Details LBPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,820	Closed	-$57K	–	560
2021 Q1	$57K	Buy	+4,820	New	+$60.1K	0.01%	418

Other funds holding LBPS

Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Context Capital Management's LBPS Position: Q2 2021 in Review

Context Capital Management sold out of 4D Pharma PLC (LBPS) in Q2 2021, closing a stake of 4,820 shares — an estimated $57K sold.

Context Capital Management first reported a position in LBPS in Q1 2021 and held it in 1 quarter. The position peaked at $57K in Q1 2021. 4 funds tracked by Wall St. Rank hold LBPS as of Q2 2021.

Context Capital Management reported no remaining 4D Pharma PLC position as of Q2 2021 after selling out during the quarter.
Context Capital Management sold 4,820 4D Pharma PLC shares in Q2 2021, an estimated $57K.
Context Capital Management first reported a position in 4D Pharma PLC in Q1 2021 and held it in 1 quarter.
Context Capital Management's 4D Pharma PLC position peaked at $57K in Q1 2021.
4 funds tracked by Wall St. Rank held 4D Pharma PLC as of Q2 2021.

Based on Context Capital Management's 13F filing for Q2 2021, filed 17 Aug 2021.